We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
-16.94%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$11.9B
AUM Growth
-$3.87B
Cap. Flow
-$755M
Cap. Flow %
-6.32%
Top 10 Hldgs %
21.67%
Holding
1,534
New
61
Increased
492
Reduced
593
Closed
262

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$59.4M
2
BABA icon
Alibaba
BABA
+$52.4M
3
UNH icon
UnitedHealth
UNH
+$43.7M
4
ABT icon
Abbott
ABT
+$42.2M
5
AGN
Allergan plc
AGN
+$40.4M

Sector Composition

Rank Sector Weight
1 Technology 23.72%
2 Healthcare 19.62%
3 Financials 12.72%
4 Consumer Discretionary 10.57%
5 Communication Services 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADSK icon
51
Autodesk
ADSK
$51.8B
$48.9M 0.41%
313,196
+50,946
+19% +$9.35M
ECL icon
52
Ecolab
ECL
$79.8B
$48.3M 0.4%
309,684
+104,580
+51% +$19.7M
HUM icon
53
Humana
HUM
$43.9B
$47.7M 0.4%
151,791
-440
-0.3% -$148K
BSX icon
54
Boston Scientific
BSX
$68.4B
$47.5M 0.4%
1,455,463
+409,999
+39% +$16M
BMY icon
55
Bristol-Myers Squibb
BMY
$129B
$47M 0.39%
843,023
-100,257
-11% -$6.13M
LOW icon
56
Lowe's Companies
LOW
$121B
$46.8M 0.39%
543,496
+234,794
+76% +$25.7M
GILD icon
57
Gilead Sciences
GILD
$165B
$45.4M 0.38%
607,906
-80,746
-12% -$5.58M
CVS icon
58
CVS Health
CVS
$135B
$44.8M 0.38%
755,424
+436,354
+137% +$29.1M
UNP icon
59
Union Pacific
UNP
$174B
$43.8M 0.37%
310,698
-160,315
-34% -$26.5M
BIIB icon
60
Biogen
BIIB
$30.9B
$42.1M 0.35%
133,144
-10,479
-7% -$3.18M
RVTY icon
61
Revvity
RVTY
$12.6B
$41.9M 0.35%
556,673
+46,993
+9% +$4.17M
MCK icon
62
McKesson
MCK
$104B
$41.9M 0.35%
309,705
-111,709
-27% -$16.4M
BRK.B icon
63
Berkshire Hathaway Class B
BRK.B
$1.1T
$41.7M 0.35%
228,167
-27,666
-11% -$5.88M
CL icon
64
Colgate-Palmolive
CL
$74.8B
$40.2M 0.34%
606,025
+305,370
+102% +$21.5M
CI icon
65
Cigna
CI
$78.4B
$40.2M 0.34%
226,844
+176,192
+348% +$34.2M
IDXX icon
66
Idexx Laboratories
IDXX
$44.9B
$39.5M 0.33%
162,857
-28,545
-15% -$7.45M
XYL icon
67
Xylem
XYL
$28.5B
$38.9M 0.33%
596,953
-69,211
-10% -$5.45M
HSY icon
68
Hershey
HSY
$37.3B
$38.4M 0.32%
290,001
-29,717
-9% -$4.38M
NKE icon
69
Nike
NKE
$64.1B
$38.3M 0.32%
462,594
+160,595
+53% +$14.9M
NEM icon
70
Newmont
NEM
$96.2B
$38.2M 0.32%
843,833
+142,474
+20% +$6.43M
ADP icon
71
Automatic Data Processing
ADP
$109B
$37.9M 0.32%
277,450
+21,143
+8% +$3.41M
PLD icon
72
Prologis
PLD
$136B
$37.4M 0.31%
465,299
-149,222
-24% -$13M
MCD icon
73
McDonald's
MCD
$193B
$37M 0.31%
223,636
+69,325
+45% +$13.7M
AMD icon
74
Advanced Micro Devices
AMD
$700B
$36.9M 0.31%
810,400
+377,453
+87% +$18.2M
COST icon
75
Costco
COST
$432B
$36.7M 0.31%
128,704
+75,908
+144% +$23M

Similar funds

KBC Group's Q1 2020 Portfolio in Review

As of Q1 2020, KBC Group held 1,534 positions worth $11.9B, down 24% from $15.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

KBC Group withdrew a net $755M in Q1 2020, closing 262 positions and reducing 593 holdings. Its most notable exit was TransDigm Group, an estimated $18M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, KBC Group opened a new position in Ingersoll Rand worth $12.3M.

  • KBC Group's largest Q1 2020 buy was Ingersoll Rand: 495,850 shares worth $12.3M.
  • KBC Group added most to Medtronic in Q1 2020, an estimated $59.4M increase.
  • KBC Group's biggest Q1 2020 reduction was Alphabet (Google) Class A, cutting an estimated $59.1M.
  • KBC Group fully exited TransDigm Group in Q1 2020, selling an estimated $18M.
  • KBC Group's ten largest holdings make up 22% of its $11.9B portfolio in Q1 2020.
  • KBC Group opened 61 new positions and closed 262 in Q1 2020.
  • KBC Group's portfolio value fell 24% quarter-over-quarter to $11.9B.

Based on KBC Group's 13F filing for Q1 2020, filed 4 May 2020.